„
  չ
  Ӗ&v
  N&
  ˾„
 
 
  -> „ -> Ӗ&v    
 
MED PrestoϵyϺWORKSHOP
Դ: Admin    •rg: 2019-04-16    g[: 506 ˴

 


 

MED64 PrestoĿǰЈ`ĸͨMEAķŴMEA嶼nj`ȶOӋVIJɼʹϵy܉ӛBĶļMED64 PrestoҲӛ䛏VĿ܁ԪĄλصĵ•ԭʼ^Vlʷܮaɿ͸؏͵ĔĶʹMED64 PrestoɞоKx


422-25RƼڱϺչ_3MED64 PrestoϵyWORKSHOPЌչʾgӭdȤώ

 

MED64 Presto

ڲͬ񽛼ϵ푪

rg
2019422̖  10:30
͔
c AWtWD206
v Gary Cheng, MD

v
늻wһNҪԪоҪIMED64ƽ΢늘OӛϵyǺõĶͨоձAlpha MED˾°l®aƷMED64 PrestoSʹ߷ݵČB񽛼ļɼȲMzyʹ߿Ɍ񽛼ײ΢늘O·ĶװBg̖BӺװ Prestoϵyӛ䛼늉΢늉ֱԼٵĔɼlʿԴ_܉򾫴_ԔMӛÿһλ  װ384늘Oͬrһɔ_زɼӛ䛔ÿеĸܶ늘O҂һݓSϢČ棺HHІ΂ĹȺwļһwОPrestoӛ䛲Ԫhλͬ늻mڰdB@ʮӛʹģͺ񽛶Ե񽛿ƌWо


MED64 Presto

Rǰˎﰲȫuđ

rg
2019424̖  10:30
͔
c ߿Ƽ@^·965̖10̖108
v Gary Cheng, MD

v

yӋˎкKԌµˎﳷؾռ42%uˎK^ȥͨhERGԇRԇȥurˎKȫhERG^ʵļԺͼRԇ򞻨M޴ܕˎаlMһˎKԵęzy FDA  2013 ׆ Comprehensive in vitro Proarrhythmia Assay (CiPA) ĿּڽRǰˎѪΣUuwϵ˜˜ CiPA ĿеһҪMɲʹ΢늘OУMEAgӛ䛸ɼTֻԴļ픵RǰKԺYĘ˜֮һ


ձAlphaMED˾һֱڸ`΢늘Oмgаl°l®aƷMED64 PrestotᘌCiPAĿ΢늘Oӛ䛷TĶܸɼhiPSCֻļλˎúļ텢ĸ׃AʾڵˎKMED64ӛ߀Ƿʽ˲p@ʹmͬһBӱMLrӛ䛺؏ӛSOҕBˎ̼푑^Lrg׃@һˎlFͰȫYṩ˸ͨ


ԴipsԴļ

rg
2019425̖  14:00
͔
c Ϻ·320̖ϺƌWоԺƌWA1704 
v Gary Cheng, MD
v

ɼֻļ񽛼оѪܺϵyίCƵļģɸɼֻļܮaйɵտsKˎƵķʹøɼֻļɞѪܼlCƼίоˎKurѼģɶTɼֻ񽛼ĿǰҲɞdB@ģʹģ񽛶о


MED64ƽ΢늘OӛϵyǺõĶͨоձAlphaMED˾°l®aƷMED64 PrestoSʹ߷ݵČB񽛼ļɼȲMzyԇֱ늘OͿ|BSyֱľֲ׃ͬrӛ䛶̖MED64ӛ߀Ƿʽ˲p@ʹmͬһBӱMLrӛ䛺؏ӛSOҕBˎ̼푑^Lrg׃




gӭPעR΢

˽Ϣ


RƼ޹˾

Bio-Gene Technology Ltd.

VݲRƼ޹˾

ᾀ176 2009 3784

㽭15ѡ5 www.oliqz.com

[email protected]

Ϻ V ɶ h



 
 
 
 

ľW      @

  ©1993-2020 ۲RƼ޹˾  |  I]  |  
ۿ˾ַɳﰲƽְ̖_Ķʮʮ    Ԓ+852-26466101    棺+852-2686 8806    E-mail㽭15ѡ5
Ї“jcVݲRƼ޹˾    “ϵԒ176 2009 3784    E-mail[email protected]